口服依地酸钙钠治疗铅中毒。
Oral calcium disodium versenate in treatment of lead poisoning.
作者信息
WILLIAMS J D, MATTHEWS G A, JUDD A W
出版信息
Br J Ind Med. 1962 Jul;19(3):211-5. doi: 10.1136/oem.19.3.211.
Abstract
A clinical trial of oral calcium disodium versenate (E.D.T.A.) in eight lead workers is described. A short course of versenate given while the men continued at work produced no side-effects. Complete overhaul of the processes and protective devices was made in the factory. Clinical, biochemical, and haematological improvement followed the removal of up to 250 mg. lead in each case. The mode of action and possible uses and abuses of oral versenate are discussed.
摘要
本文描述了对八名铅作业工人进行口服依地酸钙钠（E.D.T.A.）的临床试验。在工人继续工作的同时给予短疗程的依地酸钙钠未产生副作用。工厂对生产流程和防护设备进行了全面检修。在每例患者体内铅含量去除高达250毫克后，临床、生化及血液学指标均有改善。文中还讨论了口服依地酸钙钠的作用方式以及可能的用途和滥用情况。
相似文献
1
Oral calcium disodium versenate in treatment of lead poisoning.
Br J Ind Med. 1962 Jul;19(3):211-5. doi: 10.1136/oem.19.3.211.
2
[Detection and ambulatory treatment by oral route of lead poisoning by calcium disodium versenate (EDTA: CA Na 2)].
Maroc Med. 1961 Apr;40:377-82.
3
[Oral treatment of saturnism with calcium versenate. Clinical and experimental study].
Dia Med. 1961 Oct 5;33:2292-4.
4
[Oral and intravenous versenate in the therapy of chronic lesions caused by lead].
Minerva Med. 1962 Jul 7;53:2092-7.
5
[Lead poisoning treated with calcium versenate (disodium calcium ethylenediamine tetra-acetate)].
Ned Tijdschr Geneeskd. 1956 Oct 27;100(43):3078-82.
6
[Aspects of the elimination of lead in saturnism during treatment with Versenate].
Folia Med (Napoli). 1962 Feb;45:89-104.
7
Value of calcium disodium ethylenediaminetetraacetate and British anti-lewisite in therapy of lead poisoning.
Fed Proc. 1961 Sep;20(3)Pt 2:196-9.
8
Calcium disodium edathamil therapy of lead intoxication. The significance of amino-aciduria.
Arch Environ Health. 1961 Nov;3:563-7. doi: 10.1080/00039896.1961.10663073.
9
[Therapy of lead poisoning by Hungarian-made calcium disodium ethylenediamine tetraacetate (Ca EDTA) marked as E. Gy. T. 1271].
Orv Hetil. 1959 Jul 26;100:1081-4.
10
A comparison of intravenous calcium disodium versenate and oral penicillamine in promoting elimination of lead.
Can Med Assoc J. 1958 Oct 15;79(8):664-6.
引用本文的文献
1
The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.
Cells. 2020 Jul 16;9(7):1704. doi: 10.3390/cells9071704.
本文引用的文献
1
The measurement of lead absorption in industry.
Ann Occup Hyg. 1961 Jun;3:247-63.
2
The diagnostic and therapeutic use of edathamil calcium disodium (EDTA, versene) in excessive inorganic lead absorption.
Q J Med. 1958 Jan;27(105):65-82.
3
Treatment of lead poisoning by edathamil calcium-disodium.
AMA Arch Ind Health. 1956 May;13(5):489-98.
4
Effect of oral edathamil calcium-disodium on urinary and fecal lead excretion; comparative excretory studies with intravenous therapy.
AMA Arch Ind Health. 1956 Apr;13(4):366-71.
5
6
Treatment of chronic lead-poisoning with calcium disodium versenate.
Br Med J. 1955 Oct 8;2(4944):883-5. doi: 10.1136/bmj.2.4944.883.
7
Treatment of lead poisoning with calcium disodium versenate.
Lancet. 1955 Jan 22;268(6856):183-5. doi: 10.1016/s0140-6736(55)91910-3.
8
Misuse of edathamil calciumdisodium for prophylaxis of lead poisoning.
J Am Med Assoc. 1955 Jan 22;157(4):341-2.
9
Oral calcium EDTA in lead intoxication of children.
J Pediatr. 1954 Sep;45(3):297-301. doi: 10.1016/s0022-3476(54)80193-4.
10
The metabolism of C14 labeled ethylenediaminetetraacetic acid in human beings.
J Lab Clin Med. 1954 Apr;43(4):566-71.
Zotero 插件